outfox

Funds / institutions · SEC Form 13F

What institutions reported holding

Search 381,214 reported position rows across 20 reporting entities and their collected quarters. Explore the holdings behind the names.

Collection dates and how to read these holdings

Partial manager coverage. Form 13F reports quarter-end holdings, usually filed later; not exact trades, transaction dates, current portfolios or ETF constituent data. Short positions, some securities, confidential holdings and unreviewed amendments may be absent. CUSIP and issuer names are preserved as filed; ticker/issuer-CIK matching is not inferred. Values use the SEC filing-date format (USD from January 3, 2023; thousands of USD before). Available valid filings are searchable even without comparison quarters. Combination reports and confidential-omission flags describe incomplete reported portfolios; only disclosed positions are shown, with no inferred missing holdings. Separate reporting entities remain separate. The latest quarter is partial as filings arrive; earlier reviewed snapshots remain searchable.

51 source-checked filings. A reported portfolio snapshot—not executed trades. Histories may be incomplete; missing data does not mean no holdings. Featured investor names identify associated management firms, not personal portfolios.

  • Third Point LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:43.118Z
  • APPALOOSA LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:41.303Z
  • VANGUARD GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:55.910Z
  • TWO SIGMA INVESTMENTS, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:27.467Z
  • Pershing Square Capital Management, L.P.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:37.679Z
  • STATE STREET CORP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:58.075Z
  • COATUE MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:31.488Z
  • TIGER GLOBAL MANAGEMENT LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:33.886Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:25.387Z
  • GOLDMAN SACHS GROUP INC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:08.805Z
  • Bridgewater Associates, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:29.574Z
  • Duquesne Family Office LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:45.054Z
  • JPMORGAN CHASE & CO: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:03.721Z
  • TCI FUND MANAGEMENT LTD: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:46.863Z
  • PERSHING SQUARE INC.: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:39.481Z
  • Altimeter Capital Management, LP: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:35.674Z
  • MORGAN STANLEY: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:12.934Z
  • FMR LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:00.998Z
  • Berkshire Hathaway Inc: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:13:54.052Z
  • CITADEL ADVISORS LLC: filed 2026-01-01–2026-10-16; collected 2026-10-18T03:14:21.575Z
  • RENAISSANCE TECHNOLOGIES LLC: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:59.260Z
  • MORGAN STANLEY: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:53.319Z
  • STATE STREET CORP: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:33.733Z
  • JPMORGAN CHASE & CO: filed 2026-06-30–2026-11-15; collected 2026-11-16T03:25:48.410Z

Reported positions

381,214 matching source rows · Page 711 of 15,249. A security can appear in multiple quarters or reporting entities.

ISHARES U.S. MEDICAL DEVICES

FUND · CUSIP 464288810

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$12,927,664
Reported shares
249617
Source units and reporting details

Value as filed: 12927664 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 249617, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. MEDICAL DEVICES

FUND · CUSIP 464288810

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$82,346
Reported shares
1590
Source units and reporting details

Value as filed: 82346 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 1590, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. MEDICAL DEVICES

FUND · CUSIP 464288810

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$4,023,358
Reported shares
77686
Source units and reporting details

Value as filed: 4023358 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 77686.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. MEDICAL DEVICES

FUND · CUSIP 464288810

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$566,427
Reported shares
10937
Source units and reporting details

Value as filed: 566427 USD. Discretion code: DFND. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 10937.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$7,586
Reported shares
137
Source units and reporting details

Value as filed: 7586 USD. Discretion code: OTR. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 137.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1
Reported shares
0
Source units and reporting details

Value as filed: 1 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 0.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$21,994,238
Reported shares
397223
Source units and reporting details

Value as filed: 21994238 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 397223.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$93,022
Reported shares
1680
Source units and reporting details

Value as filed: 93022 USD. Discretion code: DFND. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 1680.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,686,054
Reported shares
30450
Source units and reporting details

Value as filed: 1686054 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 30450.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$110,961
Reported shares
2004
Source units and reporting details

Value as filed: 110961 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 2004, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$219,040,060
Reported shares
3955933
Source units and reporting details

Value as filed: 219040060 USD. Discretion code: DFND. Filing-local manager numbers: 11. Voting authority: sole 0, shared 0, none 3955933.

Included managers attributed to this row:

  • J.P. Morgan Private Investments Inc. · 13F file 028-16931

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$388
Reported shares
7
Source units and reporting details

Value as filed: 388 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 7, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. HEALTHCARE PROV

FUND · CUSIP 464288828

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$5,537
Reported shares
100
Source units and reporting details

Value as filed: 5537 USD. Discretion code: DFND. Filing-local manager numbers: 23. Voting authority: sole 100, shared 0, none 0.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$34,973
Reported shares
342
Source units and reporting details

Value as filed: 34973 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 342.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$37,223
Reported shares
364
Source units and reporting details

Value as filed: 37223 USD. Discretion code: OTR. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 364.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$3,421,456
Reported shares
33458
Source units and reporting details

Value as filed: 3421456 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 0, shared 0, none 33458.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$186,318
Reported shares
1822
Source units and reporting details

Value as filed: 186318 USD. Discretion code: DFND. Filing-local manager numbers: 4. Voting authority: sole 1822, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Investment Management Inc. · 13F file 028-11937

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$88,148
Reported shares
862
Source units and reporting details

Value as filed: 88148 USD. Discretion code: DFND. Filing-local manager numbers: 23. Voting authority: sole 862, shared 0, none 0.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$30,664,502
Reported shares
299868
Source units and reporting details

Value as filed: 30664502 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 299868, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$3,715,196
Reported shares
36330
Source units and reporting details

Value as filed: 3715196 USD. Discretion code: DFND. Filing-local manager numbers: 11. Voting authority: sole 0, shared 0, none 36330.

Included managers attributed to this row:

  • J.P. Morgan Private Investments Inc. · 13F file 028-16931

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$5,804,380
Reported shares
56761
Source units and reporting details

Value as filed: 5804380 USD. Discretion code: DFND. Filing-local manager numbers: 2. Voting authority: sole 0, shared 0, none 56761.

Included managers attributed to this row:

  • JPMorgan Chase Bank, N.A. · 13F file 028-00123

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES US PHARMACEUTICALS E

FUND · CUSIP 464288836

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$44,483
Reported shares
435
Source units and reporting details

Value as filed: 44483 USD. Discretion code: DFND. Filing-local manager numbers: 1. Voting authority: sole 0, shared 0, none 435.

Included managers attributed to this row:

  • J.P. Morgan Trust Co of Delaware · 13F file 028-12125

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. OIL EQUIPMENT &

FUND · CUSIP 464288844

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$222,640
Reported shares
8323
Source units and reporting details

Value as filed: 222640 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 8323.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. OIL EQUIPMENT &

FUND · CUSIP 464288844

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—defined. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$1,873
Reported shares
70
Source units and reporting details

Value as filed: 1873 USD. Discretion code: DFND. Filing-local manager numbers: 5. Voting authority: sole 70, shared 0, none 0.

Included managers attributed to this row:

  • J.P. Morgan Securities LLC · 13F file 028-11925

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗

ISHARES U.S. OIL & GAS EXPLO

FUND · CUSIP 464288851

Reporting manager: JPMORGAN CHASE & CO · CIK 0000019617

Discretion: shared—other. These are reported positions, not separate purchases by each included manager.

Quarter ended
2026-09-30
Filed
2026-11-12
Reported value (USD)
$64,284
Reported shares
487
Source units and reporting details

Value as filed: 64284 USD. Discretion code: OTR. Filing-local manager numbers: 23. Voting authority: sole 0, shared 0, none 487.

Included managers attributed to this row:

  • 55I, LLC · 13F file 028-19649

Accession 0000019617-26-000404. No ticker or issuer CIK has been inferred from this CUSIP. Shared positions must not be added across managers without checking for duplicate reporting.

Original SEC submission ↗